Connection

Dimitrios Giannis to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Dimitrios Giannis has written about Clinical Trials, Phase III as Topic.
Dimitrios Giannis
Connection Strength
0.041
Clinical Trials, Phase III as Topic
  1. Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Dec; 121(12):1684-1695.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.